OptiPin
MOTS-C: uses, dosing & the facts
Mitochondrial-derived peptide MOTS-C (Mitochondrial Open Reading Frame of the 12S rRNA Type-C) that regulates metabolic function and exercise capacity. Naturally produced in mitochondria. This is an evidence-graded reference — what it is, what it's used for, typical reported dosing, half-life, side effects, and how to track it. It is educational, not medical advice or a recommendation to use a research compound.
- • MOTS-C — Fat loss. Mitochondrial-derived peptide MOTS-C (Mitochondrial Open Reading Frame of the 12S rRNA Type-C) that regulates metabolic function and exercise capacity.
- • Commonly used for metabolic health optimization, exercise capacity and endurance, insulin sensitivity improvement.
- • Half-life: Approximately 3-4 hours.
- • Status: Research use only · not FDA-approved — an educational reference, not a dose protocol or sourcing advice.
What MOTS-C is
Mitochondrial-derived peptide MOTS-C (Mitochondrial Open Reading Frame of the 12S rRNA Type-C) that regulates metabolic function and exercise capacity. Naturally produced in mitochondria.
What MOTS-C is used for
- • Metabolic health optimization
- • Exercise capacity and endurance
- • Insulin sensitivity improvement
- • Anti-aging and longevity
- • Muscle function enhancement
- • Obesity and metabolic syndrome support
These are reported/community uses, not proven clinical outcomes. Most research peptides have limited human trial data behind such claims.
Typical reported dosing
| Injectable | 5-15mg per week total, split into 2 subcutaneous injections (2x/week), or dosed as 5mg every 5 days |
Presented as commonly-reported patterns for information only — not a dose recommendation. MOTS-C dosing is a decision for a qualified clinician.
Reconstitution
Reconstitute 5-10mg vial with 2mL bacteriostatic water. 2.5mg = varies by vial size. The arithmetic is the same for any peptide: concentration = vial mg ÷ water mL, and on a U-100 syringe 100 units = 1 mL. Compute your own vial with the reconstitution calculator.
Half-life & cycling
Half-life: Approximately 3-4 hours. Half-life drives dosing frequency and how quickly the compound clears — see it plotted on the half-life visualizer.
Cycling
Typically run in short cycles, not continuously. A common approach is ~4 weeks on, 4 weeks off (5-15mg/week split across 2 injections). Another popular protocol is 5mg every 5 days for ~20 days (4 injections), then a 3-4 month break - around 2-3 cycles per year. Most effective combined with exercise.
Side effects & warnings
- • Generally well-tolerated
- • Minimal side effects reported
- • Mild injection site reactions possible
Research use only. Naturally occurring mitochondrial peptide. Very promising for metabolic health. Works best when combined with regular exercise. Expensive but may have significant metabolic benefits. Newer research peptide with growing evidence base.
Tracking MOTS-C in OptiPin
If you're tracking a MOTS-C protocol, OptiPin logs each dose with reminders and site rotation, charts the outcome you care about over your dose timeline, keeps per-vial inventory with runout warnings, and (where relevant) does the reconstitution math — all on-device, no account.
Log doses, outcomes & vials in OptiPin
Reminders, outcome-over-dose charts, vial runout warnings, and built-in reconstitution math — all on-device.
Download on the App StoreFAQ
What is MOTS-C?
Mitochondrial-derived peptide MOTS-C (Mitochondrial Open Reading Frame of the 12S rRNA Type-C) that regulates metabolic function and exercise capacity. Naturally produced in mitochondria.
What is MOTS-C used for?
Commonly discussed uses include: metabolic health optimization, exercise capacity and endurance, insulin sensitivity improvement, anti-aging and longevity, muscle function enhancement, obesity and metabolic syndrome support. These are reported uses, not proven outcomes or a recommendation.
How is MOTS-C dosed?
Commonly reported dosing: Injectable — 5-15mg per week total, split into 2 subcutaneous injections (2x/week), or dosed as 5mg every 5 days. This reflects patterns discussed in the community and is presented for information only, not as a dose recommendation — MOTS-C is not an approved medicine and dosing should involve a qualified clinician.
How do you reconstitute MOTS-C?
Reconstitute 5-10mg vial with 2mL bacteriostatic water. 2.5mg = varies by vial size. On a U-100 syringe, 100 units = 1 mL. Concentrations vary by vial, so compute from your own vial with a reconstitution calculator.
What is MOTS-C's half-life?
Approximately 3-4 hours. Half-life shapes how often it is dosed and how quickly it clears.
What are MOTS-C's side effects?
Reported effects include: generally well-tolerated, minimal side effects reported, mild injection site reactions possible. Because it is a research compound, its safety profile is not fully characterized; discuss risks with a clinician.
Evidence & further reading
- Search the peer-reviewed literature for MOTS-C on PubMed (entry point to the primary evidence base, not a specific citation).
- MOTS-C on ClinicalTrials.gov — registered human trials, if any.
- US FDA / 503A compounding status of research peptides (2026).
- OptiPin peptides guide — categories, evidence grading, and how to run a protocol honestly.
Related
SLU-PP-332 · Tesofensine · 5-Amino-1MQ · AOD-9604 · Tirzepatide (Mounjaro/Zepbound) · Reconstitution calculator · All peptides